Meeting Dates and Locations / Course Director
November 11, 2008
6:00pm – 9:15 pm
SUNYDownstateMedicalCenter
395 Lenox Road
Brooklyn, New York / Michelle Tropper, MPH
VP Strategic Health Initiatives
American Cancer Society, Eastern Division, Inc.
Target Audience / Registration Fee (s)
Primary care and specialty care provider groups; Internal Medicine, Family Medicine, Gastroenterologists, Osteopaths, Physician Assistants and Registered Nurses / No Fee for participants of this program.
CME CertificateFee $20. Payable to SUNY/OCME
Course Description / Credits
This course is designed for Health care providers who treat lung cancer patients and should be aware of the various modalities of non invasive and invasive testing, as well as medical, surgical or combined management treatment strategies based on staging and patient function. / 2
Objectives:
At the conclusion of this activity, the participant should be able to:
(1) Increase primary care practitioners’ knowledge on the evidence for mammography, screening and strengthen their commitment to screening their patients
(2) Inform primary care practitioner’s knowledge of screening recommendations for the elderly based on recent study
(3)Obtain feedback from primary care practitioners on tools and resources needed to increase mammography screening rates in their practices.
To register for the meeting, or for more information, please e-mail
Accreditation
The State University of New York (SUNY) DownstateMedicalCenter is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The SUNYDownstateMedicalCenter designates this educational activity for a maximum of 2AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Policy:
SUNY Downstate Medical Center Office of CME (OCME) and its affiliates are committed to providing educational activities that are objective, balanced and as free of bias as possible. The OCME has established policies that will identify and resolve all conflicts of interest prior to this educational activity. All participating faculty are expected to disclose to the audience, verbally or in writing, any commercial relationships that might be perceived as a real or apparent conflict of interest related to the content of their presentations, and unlabeled/unapproved uses of drugs and devices. Detailed disclosures will be made verbally and/or in writing during the program.